⚠️ Research Use Only. This post is educational and does not constitute medical advice. All peptides discussed are sold for research purposes only. See our full disclaimer.
Aggressive metabolic stack for body recomposition research
Overview
The fat loss stack combines compounds targeting fat metabolism from multiple angles — appetite suppression, direct lipolysis, visceral fat reduction, and mitochondrial function. The combination produces synergistic effects beyond what any single compound achieves.
Peptides in This Stack
Semaglutide
Metabolic · High
Semaglutide is a GLP-1 receptor agonist with significant clinical research behind it for metabolic health.
AOD-9604
Metabolic · Low
AOD-9604 is a fragment of human growth hormone studied for its fat metabolism properties without affecting blood sugar.
Tesamorelin
Growth Hormone · High
Tesamorelin is an FDA-approved GHRH analog studied extensively for visceral fat reduction and metabolic health.
MOTS-c
Longevity · Moderate
MOTS-c is a mitochondrial-derived peptide studied for metabolic regulation, insulin sensitivity, and exercise capacity.
Stack Rationale
Semaglutide provides appetite suppression and improved glucose regulation through GLP-1 receptor agonism. AOD-9604 specifically targets lipolysis without affecting glucose. Tesamorelin reduces visceral adipose tissue specifically through GH-mediated mechanisms. MOTS-c supports mitochondrial function and metabolic gene expression, which becomes more important during caloric restriction.
Research Protocol
Sample protocol: Semaglutide 0.25 mg/week subq, titrating to 1-2.4 mg over weeks per FDA labeling. AOD-9604 250-500 mcg/day subq fasted morning. Tesamorelin 1-2 mg/day subq pre-bed. MOTS-c 5-10 mg subq 3x weekly. Run 12-16 weeks then assess.
The above represents protocols reported in research literature and research community use. These are not recommendations for human dosing or self-administration.
Reported Research Outcomes
Researchers commonly report substantial weight loss (12-20% body weight over 4-6 months in research contexts), visceral fat reduction visible on imaging, and improved metabolic markers. Lean mass preservation is better than with caloric restriction alone.
Cautions & Considerations
Stacking multiple metabolic peptides amplifies side effects. Nausea and GI effects from Semaglutide can be significant. Tesamorelin can cause fluid retention and IGF-1 elevation requiring monitoring. Not appropriate without baseline metabolic workup.
Research Use Only — Compliance Notice
The peptides discussed in this stack are sold for research purposes only. None of this content is medical advice or intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA. Always consult a qualified medical professional before considering any peptide-related protocols.
